Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gloo Holdings Inc Ordinary | Scott Beck | Director, President and CEO, Ten Percent Owner | 20 Nov 2025 | 15,984,099 | 28,759,750 | - | - | Class B Common Stock | ||
| TeraWulf Inc | Paul B. Prager | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 Nov 2025 | 3,000,000 | 35,554,688 | - | - | Common stock, $0.001 par value per share | |
| Bit Digital Inc | Erke Huang | Director, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.18 per share. | 20 Nov 2025 | 1,089,364 | 1,585,636 (10%) | 7% | 2.2 | 2,374,814 | Ordinary Shares, $.01 par value |
| Mineralys Therapeutics Inc | Brian Taylor Slingsby | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 43.35 per share. | 20 Nov 2025 | 1,000,000 | 7,903,838 | - | 43.4 | 43,350,000 | Common Stock |
| Edible Garden AG Inc | James E. Kras | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 988,247 | 988,247 | - | - | Stock Option (Right to Buy) | |
| AMKOR Tech Inc | Susan Y. Kim | Director, Ten Percent Owner, Member of 10% owner group (10) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 965,000 | 4,418,610 (1%) | 0% | 0 | Common Stock | |
| AMKOR Tech Inc | Susan Y. Kim | Director, Ten Percent Owner, Member of 10% owner group (10) | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 965,000 | 3,453,610 (1%) | 0% | 0 | Common Stock | |
| Edible Garden AG Inc | James E. Kras | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 934,579 | 934,579 | - | - | Restricted Stock Units | |
| Palantir | Alexander C. Karp | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 877,500 | 19,305,000 | - | - | Restricted Stock Units | |
| Palantir | Alexander C. Karp | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 877,500 | 51,258,407 | - | - | Class B Common Stock | |
| AMKOR Tech Inc | Susan Y. Kim | Director, Ten Percent Owner, Member of 10% owner group (10) | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 876,000 | 2,607,000 (1%) | 0% | 0 | Common Stock | |
| AMKOR Tech Inc | Susan Y. Kim | Director, Ten Percent Owner, Member of 10% owner group (10) | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 876,000 | 5,332,494 (2%) | 0% | 0 | Common Stock | |
| AFC Gamma Inc | Leonard M. Tannenbaum | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 2.74 per share. | 20 Nov 2025 | 729,927 | 5,692,098 | - | 2.7 | 2,000,000 | Common Stock |
| AMKOR Tech Inc | Susan Y. Kim | Director, Ten Percent Owner, Member of 10% owner group (10) | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 705,000 | 3,713,610 (1%) | 0% | 0 | Common Stock | |
| AMKOR Tech Inc | Agnes C. Kim | Member of 10% owner group (3) | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 705,000 | 705,000 (0%) | 0% | 0 | Common Stock | |
| Palantir | Stephen Cohen | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 675,000 | 13,531,797 | - | - | Class B Common Stock | |
| Palantir | Stephen Cohen | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 675,000 | 1,350,000 | - | - | Restricted Stock Units | |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.98 per share. | 20 Nov 2025 | 596,356 | 5,876,340 | - | 5.0 | 2,969,853 | Class A Common Stock |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.09 per share. | 20 Nov 2025 | 596,356 | 5,279,984 | - | 5.1 | 3,035,452 | Class A Common Stock |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.21 per share. | 20 Nov 2025 | 596,356 | 4,683,628 | - | 5.2 | 3,107,015 | Class A Common Stock |
| Annexon Inc | Muneer A. Satter | Director | Purchase of securities on an exchange or from another person at price $ 4.28 per share. | 20 Nov 2025 | 422,613 | 9,728,637 | - | 4.3 | 1,808,784 | Common Stock |
| Gloo Holdings Inc Ordinary | Scott Beck | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 20 Nov 2025 | 412,500 | 412,500 | - | 8 | 3,300,000 | Class A Common Stock |
| Bit Digital Inc | Erke Huang | Director, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.01 per share. | 20 Nov 2025 | 410,636 | 1,175,000 (7%) | 2% | 2.0 | 825,378 | Ordinary Shares, $.01 par value |
| Annexon Inc | Muneer A. Satter | Director | Purchase of securities on an exchange or from another person at price $ 4.48 per share. | 20 Nov 2025 | 400,000 | 9,306,024 | - | 4.5 | 1,792,000 | Common Stock |
| Catalyst Pharma Inc | Richard J. Daly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 381,948 | 2,546,695 | - | - | Options to purchase common stock | |
| Blend Labs Inc (Class A) | Nima Ghamsari | Director, HEAD OF BLEND | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 375,000 | 2,625,000 | - | - | Restricted Stock Units | |
| Blend Labs Inc (Class A) | Nima Ghamsari | Director, HEAD OF BLEND | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 375,000 | 6,803,300 | - | - | Class A Common Stock | |
| Palantir | Shyam Sankar | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 375,000 | 3,450,992 | - | - | Class B Common Stock | |
| Palantir | Shyam Sankar | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 375,000 | 750,000 | - | - | Restricted Stock Units | |
| Palantir | Alexander C. Karp | Director, See Remarks | 20 Nov 2025 | 359,325 | 6,791,583 | - | - | Class A Common Stock | ||
| Palantir | Alexander C. Karp | Director, See Remarks | 20 Nov 2025 | 359,325 | 50,996,582 | - | - | Class B Common Stock | ||
| Palantir | Stephen Cohen | Director, See Remarks | 20 Nov 2025 | 308,635 | 309,227 | - | - | Class A Common Stock | ||
| Palantir | Stephen Cohen | Director, See Remarks | 20 Nov 2025 | 308,635 | 13,223,162 | - | - | Class B Common Stock | ||
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Sale of securities on an exchange or to another person at price $ 16.91 per share. | 20 Nov 2025 | 308,477 | 296,791 (0%) | 0% | 16.9 | 5,216,346 | Common Stock |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 7.23 per share. | 20 Nov 2025 | 300,000 | 0 | - | 7.2 | 2,168,100 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.94 per share. | 20 Nov 2025 | 300,000 | 300,000 | - | 1.9 | 582,000 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 300,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Sale of securities on an exchange or to another person at price $ 16.54 per share. | 20 Nov 2025 | 297,925 | 296,791 (0%) | 0% | 16.5 | 4,927,680 | Common Stock |
| DoorDash | Tony Xu | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 196.16 per share. | 20 Nov 2025 | 282,999 | 232,040 | - | 196.2 | 55,513,084 | Class A Common Stock |
| Figure Technology Solutions | Michael Scott Cagney | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 35.26 per share. | 20 Nov 2025 | 280,847 | 6,598,146 | - | 35.3 | 9,901,626 | Class A Common Stock |
| Figure Technology Solutions | June Ou | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 35.26 per share. | 20 Nov 2025 | 280,847 | 6,598,146 | - | 35.3 | 9,901,626 | Class A Common Stock |
| DBV Tech (ADR) | Pharis Mohideen | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 253,000 | 253,000 | - | - | Employee Stock Option (right to buy) | |
| Gloo Holdings Inc Ordinary | John D. Furst | Director | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 20 Nov 2025 | 250,000 | 250,000 | - | 8 | 2,000,000 | Class A Common Stock |
| Gloo Holdings Inc Ordinary | Derek Todd Green | Director | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 20 Nov 2025 | 250,000 | 250,000 | - | 8 | 2,000,000 | Class A Common Stock |
| DoorDash | Tony Xu | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 Nov 2025 | 230,540 | 3,616,623 | - | - | Class B Common Stock | |
| DoorDash | Tony Xu | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 Nov 2025 | 230,540 | 1,500 | - | 0 | Class A Common Stock | |
| Chevron | John B. Hess | Director | Sale of securities on an exchange or to another person at price $ 150.20 per share. | 20 Nov 2025 | 226,367 | 870,602 (0%) | 0% | 150.2 | 33,999,780 | Common Stock |
| Chevron | John B. Hess | Director | Sale of securities on an exchange or to another person at price $ 150.51 per share. | 20 Nov 2025 | 220,250 | 1,182,795 (0%) | 0% | 150.5 | 33,150,312 | Common Stock |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 20 Nov 2025 | 211,948 | 215,924,630 (32%) | 0% | 1.3 | 281,891 | Common Stock |
| Nerdy Inc (Class A) | Charles Cohn | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.98 per share. | 20 Nov 2025 | 203,500 | 30,983,269 | - | 1.0 | 199,430 | Class A Common Stock |
| Innovative Soln And Support Inc | Shahram Askarpour | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 201,000 | 572,317 (3%) | 1% | - | Common Stock | |
| Innovative Soln And Support Inc | Shahram Askarpour | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 201,000 | 0 | - | - | Performance Stock Units | |
| Innovative Soln And Support Inc | Shahram Askarpour | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 201,000 | 572,317 (3%) | 1% | - | Common Stock | |
| Innovative Soln And Support Inc | Shahram Askarpour | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 201,000 | 0 | - | - | Performance Stock Units | |
| D-Wave Quantum Inc | John M. Markovich | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.92 per share. | 20 Nov 2025 | 200,000 | 1,682,874 | - | 0.9 | 184,000 | Common Stock, par value $0.0001 per share ("Common Stock") |
| D-Wave Quantum Inc | John M. Markovich | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 200,000 | 507,926 | - | - | Stock Option (right to buy) | |
| D-Wave Quantum Inc | John M. Markovich | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 22.94 per share. | 20 Nov 2025 | 200,000 | 1,482,874 | - | 22.9 | 4,588,000 | Common Stock, par value $0.0001 per share ("Common Stock") |
| Blend Labs Inc (Class A) | Nima Ghamsari | Director, HEAD OF BLEND | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.04 per share. | 20 Nov 2025 | 196,751 | 6,731,549 | - | 3.0 | 598,123 | Class A Common Stock |
| Figure Technology Solutions | Michael Scott Cagney | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.22 per share. | 20 Nov 2025 | 164,476 | 6,150,644 | - | 34.2 | 5,628,566 | Class A Common Stock |
| Figure Technology Solutions | June Ou | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.22 per share. | 20 Nov 2025 | 164,476 | 6,150,644 | - | 34.2 | 5,628,566 | Class A Common Stock |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 20 Nov 2025 | 161,818 | 216,086,448 (32%) | 0% | 1.3 | 216,027 | Common Stock |
| Gloo Holdings Inc Ordinary | Patrick P. Gelsinger | Director, See Remarks | 20 Nov 2025 | 159,745 | 159,745 | - | - | Class B Common Stock | ||
| Catalyst Pharma Inc | Steven R. Miller | Chief Op. & Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 158,454 | 1,457,963 | - | - | Options to purchase common stock | |
| Cassava Sciences Inc | Richard J. Barry | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 2.76 per share. | 20 Nov 2025 | 150,000 | 938,060 (5%) | 0% | 2.8 | 414,000 | Common Stock |
| Palantir | Shyam Sankar | See Remarks | 20 Nov 2025 | 149,872 | 792,658 | - | - | Class A Common Stock | ||
| Palantir | Shyam Sankar | See Remarks | 20 Nov 2025 | 149,872 | 3,301,120 | - | - | Class B Common Stock | ||
| CuriosityStream Inc - Ordinary Shares- Class A | Clinton Larry Stinchcomb | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.65 per share. | 20 Nov 2025 | 141,206 | 2,517,998 | - | 4.7 | 657,032 | Common Stock |
| CCC Intelligent Soln Holdings Inc | Timothy A Welsh | See Remarks | Purchase of securities on an exchange or from another person at price $ 7.31 per share. | 20 Nov 2025 | 136,720 | 305,192 | - | 7.3 | 999,929 | Common Stock |
| TPG Inc (Class A) | Nehal Raj | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 136,000 | 336,712 | - | 0 | Class A Common Stock | |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.46 per share. | 20 Nov 2025 | 133,032 | 525,755 (0%) | 0% | 8.5 | 1,125,451 | Common Stock |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 133,032 | 66,517 | - | - | Stock Option (right to buy) | |
| Walmart | John R. Furner | Executive Vice President | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 132,850 | 746,965 (0%) | 0% | 0 | Common | |
| Peloton Interactive Inc | Jennifer Cunningham Cotter | Chief Content Officer | Sale of securities on an exchange or to another person at price $ 6.64 per share. | 20 Nov 2025 | 131,495 | 100,269 (0%) | 0% | 6.6 | 873,626 | Class A Common Stock |
| Siebert Fin Corp | Gloria E. Gebbia | Director, Ten Percent Owner, Member of 10% owner group | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 128,000 | 9,569,714 (31%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Siebert Fin Corp | John J. Gebbia | Director, CEO, Ten Percent Owner, Member of 10% owner group | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 128,000 | 9,569,714 (31%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Alumis Inc | Srinivas Akkaraju | Director | Purchase of securities on an exchange or from another person at price $ 7.20 per share. | 20 Nov 2025 | 125,743 | 643,260 | - | 7.2 | 905,350 | Common Stock |
| Gloo Holdings Inc Ordinary | Patrick P. Gelsinger | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 20 Nov 2025 | 125,000 | 125,000 | - | 8 | 1,000,000 | Class A Common Stock |
| Blend Labs Inc (Class A) | Nima Ghamsari | Director, HEAD OF BLEND | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 125,000 | 625,000 | - | - | Restricted Stock Units | |
| Blend Labs Inc (Class A) | Nima Ghamsari | Director, HEAD OF BLEND | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 125,000 | 6,928,300 | - | - | Class A Common Stock | |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 20 Nov 2025 | 119,809 | 522,123 (0%) | 0% | 12.1 | 1,454,481 | Common Stock |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 119,809 | 17,161 | - | - | Stock Option (right to buy) | |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 20 Nov 2025 | 119,129 | 215,665,577 (32%) | 0% | 1.3 | 157,250 | Common Stock |
| Catalyst Pharma Inc | Richard J. Daly | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 115,283 | 2,681,984 | - | - | Restricted Stock Units | |
| Peloton Interactive Inc | Dion Camp Sanders | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 6.64 per share. | 20 Nov 2025 | 111,036 | 0 (0%) | 0% | 6.6 | 737,745 | Class A Common Stock |
| Catalyst Pharma Inc | Carmen Jeffrey Del | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 106,873 | 1,037,881 | - | - | Options to purchase common stock | |
| Catalyst Pharma Inc | Preethi Sundaram | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 106,873 | 785,305 | - | - | Options to purchase common stock | |
| Figure Technology Solutions | Michael Scott Cagney | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 38.19 per share. | 20 Nov 2025 | 106,370 | 6,391,064 | - | 38.2 | 4,061,813 | Class A Common Stock |
| Figure Technology Solutions | June Ou | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 38.19 per share. | 20 Nov 2025 | 106,370 | 6,391,064 | - | 38.2 | 4,061,813 | Class A Common Stock |
| Chime Fin Inc (Class A) | Matthew Newcomb | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 102,926 | 2,250,798 | - | 0 | Class A Common Stock | |
| Chime Fin Inc (Class A) | Matthew Newcomb | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 102,926 | 420,113 | - | 0 | Class A Common Stock | |
| IonQ Inc | Rima Alameddine | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 46.89 per share. | 20 Nov 2025 | 100,000 | 432,616 | - | 46.9 | 4,689,060 | Common Stock |
| Catalyst Pharma Inc | Brian Elsbernd | Chief Compliance/Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 98,652 | 945,161 | - | - | Options to purchase common stock | |
| Honest Co Inc (The ) | Carla Vernon | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.60 per share. | 20 Nov 2025 | 97,505 | 2,901,488 | - | 2.6 | 253,513 | Common Stock |
| Palantir | Alexander C. Karp | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 97,500 | 51,355,907 | - | - | Class B Common Stock | |
| Palantir | Alexander C. Karp | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 97,500 | 2,145,000 | - | - | Restricted Stock Units | |
| SmartRent Inc (Class A) | Frank D. Martell | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.47 per share. | 20 Nov 2025 | 93,764 | 991,968 | - | 1.5 | 137,833 | Class A Common Stock |
| Edible Garden AG Inc | Mathew McConnell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 93,457 | 93,543 | - | 0 | Common Stock | |
| Edible Garden AG Inc | Ryan Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 93,457 | 93,462 | - | 0 | Common Stock | |
| AFC Gamma Inc | Robyn Tannenbaum | President and CIO | Grant, award, or other acquisition of securities at price $ 2.74 per share. | 20 Nov 2025 | 91,240 | 218,907 | - | 2.7 | 249,998 | Common Stock |
| AFC Gamma Inc | Daniel Neville | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 2.74 per share. | 20 Nov 2025 | 91,240 | 317,889 | - | 2.7 | 249,998 | Common Stock |
| Matthews Intl Corp (Class A) | Joseph C. Bartolacci | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 90,000 | 674,953 (2%) | 0% | 0 | Class A Common Stock | |
| DraftKings Inc (Class A) | Paul Liberman | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.29 per share. | 20 Nov 2025 | 89,159 | 856,881 | - | 3.3 | 293,333 | Class A Common Stock |
| DraftKings Inc (Class A) | Paul Liberman | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 89,159 | 0 | - | - | Stock Options | |
| Innovative Soln And Support Inc | Shahram Askarpour | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.42 per share. | 20 Nov 2025 | 87,918 | 484,399 (2%) | 0% | 8.4 | 740,270 | Common Stock |
| KalVista Pharma Inc | Christopher M. Yea | CHIEF DEVELOPMENT OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 87,390 | 220,964 (1%) | 0% | 0.0 | 376 | Common Stock |
| KalVista Pharma Inc | Christopher M. Yea | CHIEF DEVELOPMENT OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 87,390 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Aurora Innovation Inc (Class A) | Shelley Webb | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.83 per share. | 20 Nov 2025 | 83,246 | 791,071 | - | 3.8 | 318,832 | Class A Common Stock |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 83,145 | 116,404 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 20 Nov 2025 | 83,145 | 605,268 (0%) | 0% | 4.0 | 331,749 | Common Stock |
| Blend Labs Inc (Class A) | Brian Kneafsey | Head of Revenue | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 75,000 | 737,909 | - | - | Class A Common Stock | |
| Blend Labs Inc (Class A) | Brian Kneafsey | Head of Revenue | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 75,000 | 75,000 | - | - | Restricted Stock Units | |
| Akero Therapeutics Inc | Andrew Cheng | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 74,538 | 436,837 (1%) | 0% | 0 | Common Stock | |
| Quanterix Corp | William P. Donnelly | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 70,091 | 70,091 | - | - | Stock Options (Right to buy) | |
| Alphatec Holdings Inc | Tyson Marshall | GENERAL COUNSEL & CORP. SEC. | Sale of securities on an exchange or to another person at price $ 19.51 per share. | 20 Nov 2025 | 70,000 | 368,331 (0%) | 0% | 19.5 | 1,365,700 | Common Stock |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 7.23 per share. | 20 Nov 2025 | 69,051 | 0 | - | 7.2 | 499,032 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 20 Nov 2025 | 69,051 | 69,051 | - | 1.7 | 120,149 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 69,051 | 229,884 | - | - | Stock Option (Right to Buy) | |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.14 per share. | 20 Nov 2025 | 68,961 | 594,716 (0%) | 0% | 12.1 | 837,187 | Common Stock |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 68,961 | 136,970 | - | - | Stock Option (right to buy) | |
| Oncology Institute Inc | Anne M. McGeorge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 67,901 | 251,247 | - | 0 | Common Stock | |
| Figure Technology Solutions | Michael Scott Cagney | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 36.11 per share. | 20 Nov 2025 | 67,517 | 6,530,629 | - | 36.1 | 2,437,776 | Class A Common Stock |
| Figure Technology Solutions | June Ou | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 36.11 per share. | 20 Nov 2025 | 67,517 | 6,530,629 | - | 36.1 | 2,437,776 | Class A Common Stock |
| Edible Garden AG Inc | Pamela DonAroma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 64,252 | 64,254 | - | 0 | Common Stock, par value $0.0001 per share | |
| Figure Technology Solutions | Michael Scott Cagney | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.33 per share. | 20 Nov 2025 | 63,873 | 6,315,120 | - | 33.3 | 2,128,759 | Class A Common Stock |
| Figure Technology Solutions | June Ou | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.33 per share. | 20 Nov 2025 | 63,873 | 6,315,120 | - | 33.3 | 2,128,759 | Class A Common Stock |
| CuriosityStream Inc - Ordinary Shares- Class A | Clinton Larry Stinchcomb | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.92 per share. | 20 Nov 2025 | 63,674 | 2,672,076 | - | 4.9 | 313,276 | Common Stock |
| Standard BioTools Inc | Michael Egholm | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.28 per share. | 20 Nov 2025 | 63,529 | 5,617,837 (7%) | 0% | 1.3 | 81,317 | Common Stock |
| Teva- pharma Ind Ltd (ADR) | Christine Fox | EVP, Head of U.S. Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 63,492 | 126,984 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Christine Fox | EVP, Head of U.S. Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 63,492 | 91,876 (0%) | 0% | - | Ordinary Shares | |
| Rocket Lab USA Inc | Jon A. Olson | Director | Sale of securities on an exchange or to another person at price $ 45.02 per share. | 20 Nov 2025 | 60,400 | 375,835 | - | 45.0 | 2,719,474 | Common Stock |
| Aurora Innovation Inc (Class A) | Ossa Fisher | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.83 per share. | 20 Nov 2025 | 59,535 | 1,852,562 | - | 3.8 | 228,019 | Class A Common Stock |
| SmartRent Inc (Class A) | Frank D. Martell | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.44 per share. | 20 Nov 2025 | 56,236 | 1,048,204 | - | 1.4 | 80,980 | Class A Common Stock |
| Aurora Innovation Inc (Class A) | David Maday | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.83 per share. | 20 Nov 2025 | 51,529 | 1,552,427 | - | 3.8 | 197,356 | Class A Common Stock |
| Cosmos Health Inc | Grigorios Siokas | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.62 per share. | 20 Nov 2025 | 51,315 | 6,271,813 | - | 0.6 | 32,000 | Common Stock, par value $.001 |
| Richmond Mutual Bancorp Inc | Garry D. Kleer | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 51,253 | 167,823 (1%) | 0% | 0 | Common Stock | |
| Oncology Institute Inc | Mohit Kaushal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 50,926 | 228,179 | - | 0 | Common Stock | |
| Upexi Inc | Gene Salkind | Director | Purchase of securities on an exchange or from another person at price $ 2.55 per share. | 20 Nov 2025 | 50,000 | 218,750 | - | 2.6 | 127,500 | Common Stock |
| Franklin Resources Inc | Charles B. Johnson | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 21.20 per share. | 20 Nov 2025 | 50,000 | 90,137,677 (18%) | 0% | 21.2 | 1,060,000 | Common Stock, par value $.10 |
| Westrock Coffee Co | Scott T. Ford | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.35 per share. | 20 Nov 2025 | 50,000 | 406,401 | - | 4.4 | 217,500 | COMMON STOCK |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 20 Nov 2025 | 49,480 | 367,939 (0%) | 0% | 6.6 | 324,094 | Common Stock |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 49,480 | 0 | - | - | Stock Option (right to buy) | |
| RingCentral Inc (Class A) | Vladimir Shmunis | Director, CEO and Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.12 per share. | 20 Nov 2025 | 48,333 | 363,983 (0%) | 0% | 26.1 | 1,262,458 | Class A Common Stock |
| Oncology Institute Inc | Karen M. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 47,840 | 251,249 | - | 0 | Common Stock | |
| Catalyst Pharma Inc | Steven R. Miller | Chief Op. & Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 47,826 | 1,489,255 | - | - | Restricted Stock Units | |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 20 Nov 2025 | 47,105 | 215,712,682 (32%) | 0% | 1.3 | 62,414 | Common Stock |
| Oncology Institute Inc | Mark L. Pacala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 46,296 | 221,267 | - | 0 | Common Stock | |
| Oncology Institute Inc | Gabriel Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 46,296 | 296,502 | - | 0 | Common Stock | |
| Palantir | Alexander C. Karp | Director, See Remarks | 20 Nov 2025 | 45,564 | 6,477,822 | - | - | Class A Common Stock | ||
| Palantir | Alexander C. Karp | Director, See Remarks | 20 Nov 2025 | 45,564 | 50,951,018 | - | - | Class B Common Stock | ||
| Matthews Intl Corp (Class A) | Joseph C. Bartolacci | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 45,000 | 0 | - | - | Restricted Share Units | |
| Palantir | Alexander C. Karp | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 172.77 per share. | 20 Nov 2025 | 44,883 | 6,436,403 | - | 172.8 | 7,754,512 | Class A Common Stock |
| Palantir | Alexander C. Karp | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 157.25 per share. | 20 Nov 2025 | 44,669 | 6,703,376 | - | 157.3 | 7,024,245 | Class A Common Stock |
| Palantir | Alexander C. Karp | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 156.26 per share. | 20 Nov 2025 | 44,593 | 6,432,803 | - | 156.3 | 6,968,107 | Class A Common Stock |
| DBV Tech (ADR) | Pharis Mohideen | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 44,000 | 145,529 (0%) | 0% | 0 | Ordinary Shares | |
| Palantir | Alexander C. Karp | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 158.14 per share. | 20 Nov 2025 | 43,582 | 6,659,794 | - | 158.1 | 6,891,905 | Class A Common Stock |
| BARK Inc (Class A) | Matt Meeker | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.66 per share. | 20 Nov 2025 | 42,258 | 12,062,736 | - | 0.7 | 27,890 | Common Stock |
| Rigetti Computing Inc | David Rivas | CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 26.34 per share. | 20 Nov 2025 | 41,935 | 688,633 | - | 26.3 | 1,104,555 | Common Stock |
| Oncology Institute Inc | Brad Hively | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 41,667 | 664,647 | - | 0 | Common Stock | |
| Fossil Grp Inc | Wendy L. Schoppert | Director | Purchase of securities on an exchange or from another person at price $ 2.47 per share. | 20 Nov 2025 | 41,322 | 43,788 (0%) | 0% | 2.5 | 102,065 | Common Stock |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 187.78 per share. | 20 Nov 2025 | 40,261 | 448,576 | - | 187.8 | 7,560,211 | Class A Common Stock |
| Oncology Institute Inc | Mohit Kaushal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 40,123 | 268,302 | - | 0 | Common Stock | |
| Oncology Institute Inc | Anne M. McGeorge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 40,123 | 291,370 | - | 0 | Common Stock | |
| Crocs Inc | Andrew Rees | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 40,000 | 775,981 (1%) | 0% | 0 | Common Stock | |
| Palantir | Alexander C. Karp | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 172.00 per share. | 20 Nov 2025 | 39,589 | 6,481,286 | - | 172.0 | 6,809,181 | Class A Common Stock |
| Matthews Intl Corp (Class A) | Joseph C. Bartolacci | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.10 per share. | 20 Nov 2025 | 39,141 | 635,812 (2%) | 0% | 25.1 | 982,439 | Class A Common Stock |
| Palantir | Stephen Cohen | Director, See Remarks | 20 Nov 2025 | 39,136 | 39,728 | - | - | Class A Common Stock | ||
| Palantir | Stephen Cohen | Director, See Remarks | 20 Nov 2025 | 39,136 | 13,184,026 | - | - | Class B Common Stock | ||
| Chime Fin Inc (Class A) | Christopher Britt | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 38,738 | 306,042 | - | 0 | Class A Common Stock | |
| Chime Fin Inc (Class A) | Christopher Britt | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 38,738 | 38,738 | - | 0 | Class A Common Stock | |
| Palantir | Stephen Cohen | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 172.77 per share. | 20 Nov 2025 | 38,551 | 4,152 | - | 172.8 | 6,660,522 | Class A Common Stock |
| Palantir | Stephen Cohen | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 157.25 per share. | 20 Nov 2025 | 38,368 | 233,463 | - | 157.3 | 6,033,406 | Class A Common Stock |
| Palantir | Stephen Cohen | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 156.26 per share. | 20 Nov 2025 | 38,303 | 1,060 | - | 156.3 | 5,985,231 | Class A Common Stock |
| Reddit Inc (Class A) | Jennifer L. Wong | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 187.78 per share. | 20 Nov 2025 | 38,113 | 1,247,955 | - | 187.8 | 7,156,859 | Class A Common Stock |
| Blend Labs Inc (Class A) | Brian Kneafsey | Head of Revenue | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.04 per share. | 20 Nov 2025 | 38,085 | 699,824 | - | 3.0 | 115,778 | Class A Common Stock |
| Sagimet Biosciences Inc (Class A) | George Kemble | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 7.69 per share. | 20 Nov 2025 | 37,688 | 81,005 | - | 7.7 | 289,979 | Series A Common Stock |
| Chevron | John B. Hess | Director | Sale of securities on an exchange or to another person at price $ 151.37 per share. | 20 Nov 2025 | 37,441 | 1,145,354 (0%) | 0% | 151.4 | 5,667,358 | Common Stock |
| Palantir | Stephen Cohen | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 158.14 per share. | 20 Nov 2025 | 37,434 | 196,029 | - | 158.1 | 5,919,682 | Class A Common Stock |
| Oncology Institute Inc | Karen M. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 37,037 | 288,286 | - | 0 | Common Stock | |
| Oncology Institute Inc | Gabriel Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 37,037 | 333,539 | - | 0 | Common Stock | |
| Oncology Institute Inc | Mark L. Pacala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 35,494 | 256,761 | - | 0 | Common Stock | |
| Catalyst Pharma Inc | Patrick J. McEnany | Director, Chairman of Board of Directors | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 34,921 | 1,873,051 | - | - | Options to purchase common stock | |
| Payoneer Global Inc | John Caplan | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.45 per share. | 20 Nov 2025 | 34,563 | 4,893,725 | - | 5.4 | 188,368 | Common Stock |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 20 Nov 2025 | 34,375 | 402,314 (0%) | 0% | 7.3 | 249,906 | Common Stock |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 34,375 | 0 | - | - | Stock Option (right to buy) | |
| Palantir | Stephen Cohen | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 172.00 per share. | 20 Nov 2025 | 34,005 | 42,703 | - | 172.0 | 5,848,751 | Class A Common Stock |
| Palantir | Alexander C. Karp | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 170.91 per share. | 20 Nov 2025 | 33,722 | 6,520,875 | - | 170.9 | 5,763,488 | Class A Common Stock |
| Meta | Susan J. Li | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 33,583 | 56,571 (0%) | 0% | 0 | Class A Common Stock | |
| Meta | Susan J. Li | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 33,583 | 68,888 (0%) | 0% | 0 | Class A Common Stock | |
| Figure Technology Solutions | Michael Scott Cagney | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 37.29 per share. | 20 Nov 2025 | 33,195 | 6,497,434 | - | 37.3 | 1,237,868 | Class A Common Stock |
| Figure Technology Solutions | June Ou | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 37.29 per share. | 20 Nov 2025 | 33,195 | 6,497,434 | - | 37.3 | 1,237,868 | Class A Common Stock |
| Fossil Grp Inc | Gail B. Tifford | Director | Purchase of securities on an exchange or from another person at price $ 2.40 per share. | 20 Nov 2025 | 33,000 | 135,925 (0%) | 0% | 2.4 | 79,200 | Common Stock |
| RingCentral Inc (Class A) | Vladimir Shmunis | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 27.22 per share. | 20 Nov 2025 | 32,623 | 317,139 (0%) | 0% | 27.2 | 888,031 | Class A Common Stock |
| Lyft Inc - Ordinary Shares Cls A | Lindsay Llewellyn | SEE REMARKS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.21 per share. | 20 Nov 2025 | 32,419 | 804,076 (0%) | 0% | 21.2 | 687,607 | Class A Common Stock |
| Oncology Institute Inc | Brad Hively | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 32,407 | 697,054 | - | 0 | Common Stock | |
| Catalyst Pharma Inc | Carmen Jeffrey Del | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 32,257 | 1,070,138 | - | - | Restricted Stock Units | |
| Catalyst Pharma Inc | Preethi Sundaram | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 32,257 | 817,562 | - | - | Restricted Stock Units | |
| CNO Fin Grp Inc | Gary C. Bhojwani | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 39.97 per share. | 20 Nov 2025 | 31,430 | 227,356 (0%) | 0% | 40.0 | 1,256,342 | Common Stock |
| Blend Labs Inc (Class A) | Winnie Ling | HEAD OF LEGAL AND PEOPLE | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 31,250 | 411,881 | - | - | Class A Common Stock | |
| Blend Labs Inc (Class A) | Winnie Ling | HEAD OF LEGAL AND PEOPLE | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 31,250 | 156,250 | - | - | Restricted Stock Units | |
| Chevron | John B. Hess | Director | Sale of securities on an exchange or to another person at price $ 149.48 per share. | 20 Nov 2025 | 31,076 | 1,096,969 (0%) | 0% | 149.5 | 4,645,175 | Common Stock |
| Evolv Tech Holdings Inc (Class A) | Richard A. Shapiro | Director | Purchase of securities on an exchange or from another person at price $ 6.00 per share. | 20 Nov 2025 | 30,000 | 52,515 | - | 6 | 180,000 | Class A Common Stock |
| TJX | Ernie L. Herrman | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 148.81 per share. | 20 Nov 2025 | 30,000 | 535,143 (0%) | 0% | 148.8 | 4,464,426 | Common Stock |
| Pure Cycle Corp | Marc S. Spezialy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 30,000 | 30,000 | - | - | Non-Statutory Stock Option (Right to Buy) | |
| Catalyst Pharma Inc | Brian Elsbernd | Chief Compliance/Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 29,776 | 975,037 | - | - | Restricted Stock Units | |
| Palantir | Stephen Cohen | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 170.91 per share. | 20 Nov 2025 | 28,965 | 76,708 | - | 170.9 | 4,950,460 | Class A Common Stock |
| Honest Co Inc (The ) | Katherine Barton | Chief Growth Officer | Sale of securities on an exchange or to another person at price $ 2.60 per share. | 20 Nov 2025 | 28,896 | 863,698 | - | 2.6 | 75,130 | Common Stock |
| Teva- pharma Ind Ltd (ADR) | Christine Fox | EVP, Head of U.S. Commercial | Sale of securities on an exchange or to another person at price $ 24.78 per share. | 20 Nov 2025 | 28,229 | 63,647 (0%) | 0% | 24.8 | 699,523 | Ordinary Shares |
| Exelixis Inc | Patrick J. Haley | EVP, Commercial | Sale of securities on an exchange or to another person at price $ 42.58 per share. | 20 Nov 2025 | 28,043 | 374,029 (0%) | 0% | 42.6 | 1,194,071 | Common Stock |
| RingCentral Inc (Class A) | Vladimir Shmunis | Director, CEO and Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.29 per share. | 20 Nov 2025 | 27,881 | 289,258 (0%) | 0% | 27.3 | 760,872 | Class A Common Stock |
| Backblaze Inc (Class A) | Gleb Budman | Director, CEO and Chairperson | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.33 per share. | 20 Nov 2025 | 27,793 | 2,096,013 | - | 4.3 | 120,344 | Class A Common Stock |
| Arista Networks | Jayshree V. Ullal | Director, CEO and Chairperson | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 27,660 | 58,177 (0%) | 0% | 0 | Common Stock | |
| Arista Networks | Jayshree V. Ullal | Director, CEO and Chairperson | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 27,660 | 138,320 | - | - | Restricted Stock Unit-8 | |
| RingCentral Inc (Class A) | Vladimir Shmunis | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 27.68 per share. | 20 Nov 2025 | 27,018 | 262,240 (0%) | 0% | 27.7 | 747,858 | Class A Common Stock |
| Siebert Fin Corp | John J. Gebbia | Member of 10% owner group | Other type of transaction at price $ 0.00 per share. | 20 Nov 2025 | 26,000 | 490,000 (1%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Siebert Fin Corp | John J. Gebbia | Member of 10% owner group | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 26,000 | 516,000 (1%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Confluent Inc (Class A) | Rohan Sivaram | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 22.51 per share. | 20 Nov 2025 | 25,858 | 599,738 | - | 22.5 | 582,064 | Class A Common Stock |
| Cloudflare Inc (Class A) | Michelle Zatlyn | Director, President and Board Co-Chair | 20 Nov 2025 | 25,641 | 50,196 (0%) | 0% | - | Class A Common Stock | ||
| Cloudflare Inc (Class A) | Michelle Zatlyn | Director, President and Board Co-Chair | 20 Nov 2025 | 25,641 | 50,196 (0%) | 0% | - | Class A Common Stock | ||
| Cloudflare Inc (Class A) | Michelle Zatlyn | Director, President and Board Co-Chair | 20 Nov 2025 | 25,641 | 59,654 (0%) | 0% | - | Class A Common Stock | ||
| Cloudflare Inc (Class A) | Michelle Zatlyn | Director, President and Board Co-Chair | 20 Nov 2025 | 25,641 | 0 | - | - | Class B Common Stock | ||
| Cloudflare Inc (Class A) | Michelle Zatlyn | Director, President and Board Co-Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 25,641 | 25,641 | - | - | Class B Common Stock | |
| Cloudflare Inc (Class A) | Michelle Zatlyn | Director, President and Board Co-Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 25,641 | 1,825,633 | - | - | Employee Stock Option (right to buy) | |
| Cloudflare Inc (Class A) | Michelle Zatlyn | Director, President and Board Co-Chair | 20 Nov 2025 | 25,641 | 0 | - | - | Class B Common Stock | ||
| Cloudflare Inc (Class A) | Michelle Zatlyn | Director, President and Board Co-Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 25,641 | 25,641 | - | - | Class B Common Stock | |
| Cloudflare Inc (Class A) | Michelle Zatlyn | Director, President and Board Co-Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 25,641 | 1,851,274 | - | - | Employee Stock Option (right to buy) | |
| Cloudflare Inc (Class A) | Michelle Zatlyn | Director, President and Board Co-Chair | 20 Nov 2025 | 25,641 | 0 | - | - | Class B Common Stock | ||
| Cloudflare Inc (Class A) | Michelle Zatlyn | Director, President and Board Co-Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 25,641 | 25,641 | - | - | Class B Common Stock | |
| Cloudflare Inc (Class A) | Michelle Zatlyn | Director, President and Board Co-Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 25,641 | 1,876,915 | - | - | Employee Stock Option (right to buy) | |
| GCT Semiconductor Holding Inc | Hyunsoo Hans Shin | Director, Class II Director | Purchase of securities on an exchange or from another person at price $ 1.28 per share. | 20 Nov 2025 | 25,453 | 737,866 | - | 1.3 | 32,580 | Common Stock |
| Gloo Holdings Inc Ordinary | John D. Furst | Director | Grant, award, or other acquisition of securities at price $ 8.00 per share. | 20 Nov 2025 | 25,000 | 275,000 | - | 8 | 200,000 | Class A Common Stock |
| Gloo Holdings Inc Ordinary | Claude Richard Alexander | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 25,000 | 25,000 | - | 0 | Class A Common Stock | |
| Gloo Holdings Inc Ordinary | Derek Todd Green | Director | Grant, award, or other acquisition of securities at price $ 8.00 per share. | 20 Nov 2025 | 25,000 | 25,000 | - | 8 | 200,000 | Class A Common Stock |
| Gloo Holdings Inc Ordinary | Elizabeth Grennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 25,000 | 25,000 | - | 0 | Class A Common Stock | |
| Gloo Holdings Inc Ordinary | Robert Gruenewald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 25,000 | 25,000 | - | 0 | Class A Common Stock | |
| Gloo Holdings Inc Ordinary | Nona Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 25,000 | 25,000 | - | 0 | Class A Common Stock | |
| Alphatec Holdings Inc | Scott Lish | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 25,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Alphatec Holdings Inc | Scott Lish | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 19.80 per share. | 20 Nov 2025 | 25,000 | 672,207 (1%) | 0% | 19.8 | 495,000 | Common Stock |
| Alphatec Holdings Inc | Scott Lish | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.63 per share. | 20 Nov 2025 | 25,000 | 697,207 (1%) | 0% | 3.6 | 90,750 | Common Stock |
| Blend Labs Inc (Class A) | Oxana Tkach | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 25,000 | 175,000 | - | - | Restricted Stock Units | |
| Blend Labs Inc (Class A) | Oxana Tkach | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 25,000 | 77,780 | - | - | Class A Common Stock | |
| National Health Investors Inc | James R. Jobe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 25,000 | 0 | - | - | Stock Options (Right to Buy) 2-25-2021 | |
| National Health Investors Inc | James R. Jobe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.20 per share. | 20 Nov 2025 | 25,000 | 53,690 (0%) | 0% | 69.2 | 1,730,000 | Common Stock - Jointly held with spouse |
| Murphy USA Inc | R. Andrew Clyde | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 381.33 per share. | 20 Nov 2025 | 24,733 | 131,024 (0%) | 0% | 381.3 | 9,431,435 | Common Stock |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.34 per share. | 20 Nov 2025 | 24,579 | 216,111,027 (32%) | 0% | 1.3 | 32,936 | Common Stock |
| TJX | Ernie L. Herrman | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 151.31 per share. | 20 Nov 2025 | 24,363 | 510,780 (0%) | 0% | 151.3 | 3,686,482 | Common Stock |
| Arista Networks | Jayshree V. Ullal | Director, CEO and Chairperson | Payment of exercise price or tax liability using portion of securities received from the company at price $ 124.81 per share. | 20 Nov 2025 | 24,218 | 33,959 (0%) | 0% | 124.8 | 3,022,649 | Common Stock |
| Confluent Inc (Class A) | Edward Jay Kreps | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 21.83 per share. | 20 Nov 2025 | 23,787 | 353,287 | - | 21.8 | 519,270 | Class A Common Stock |
| Exelixis Inc | Patrick J. Haley | EVP, Commercial | Sale of securities on an exchange or to another person at price $ 41.93 per share. | 20 Nov 2025 | 23,539 | 0 (0%) | 0% | 41.9 | 986,990 | Common Stock |
| Matthews Intl Corp (Class A) | Steven F. Nicola | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 22,800 | 219,370 (0%) | 0% | 0 | Class A Common Stock | |
| Chime Fin Inc (Class A) | Ryan King | Director, Co-Founder | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 22,475 | 22,475 | - | 0 | Common Stock | |
| Chime Fin Inc (Class A) | Ryan King | Director, Co-Founder | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 22,475 | 151,667 | - | 0 | Class A Common Stock | |
| Palantir | Alexander C. Karp | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 155.31 per share. | 20 Nov 2025 | 22,200 | 6,769,383 | - | 155.3 | 3,447,858 | Class A Common Stock |
| National Health Investors Inc | James R. Jobe | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.16 per share. | 20 Nov 2025 | 22,135 | 31,555 (0%) | 0% | 78.2 | 1,730,072 | Common Stock - Jointly held with spouse |
| Village Farms Intl Inc | Carolyn Hauger | Director | Sale of securities on an exchange or to another person at price $ 3.75 per share. | 20 Nov 2025 | 22,000 | 29,020 (0%) | 0% | 3.8 | 82,500 | Common Shares |
| Medpace Holdings Inc | August J. Troendle | Director, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 592.18 per share. | 20 Nov 2025 | 21,858 | 833,627 (2%) | 0% | 592.2 | 12,943,870 | Common Stock |
| Figure Technology Solutions | Michael Scott Cagney | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.97 per share. | 20 Nov 2025 | 21,651 | 6,128,993 | - | 35.0 | 757,036 | Class A Common Stock |
| Figure Technology Solutions | June Ou | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.97 per share. | 20 Nov 2025 | 21,651 | 6,128,993 | - | 35.0 | 757,036 | Class A Common Stock |
| Applovin Corp (Class A) | Vasily Shikin | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 520.82 per share. | 20 Nov 2025 | 21,393 | 3,350,824 | - | 520.8 | 11,141,902 | Class A Common Stock |
| Palantir | Alexander C. Karp | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 156.19 per share. | 20 Nov 2025 | 21,338 | 6,748,045 | - | 156.2 | 3,332,693 | Class A Common Stock |
| Fortrea Holdings Inc | William J. Sharbaugh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 20,916 | 20,916 | - | - | Restricted Stock Unit | |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 20 Nov 2025 | 20,834 | 318,459 (0%) | 0% | 6.6 | 136,463 | Common Stock |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 20,834 | 0 | - | - | Stock Option (right to buy) | |
| Arista Networks | Jayshree V. Ullal | Director, CEO and Chairperson | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 20,600 | 30,517 (0%) | 0% | 0 | Common Stock | |
| Arista Networks | Jayshree V. Ullal | Director, CEO and Chairperson | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 20,600 | 20,592 | - | - | Restricted Stock Unit-7 | |
| Catalyst Pharma Inc | Gregg Russo | Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 20,531 | 66,276 | - | - | Options to purchase common stock | |
| Palantir | Alexander C. Karp | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 159.08 per share. | 20 Nov 2025 | 20,275 | 6,639,519 | - | 159.1 | 3,225,319 | Class A Common Stock |
| Catalyst Pharma Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 20,006 | 246,800 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharma Inc | Richard J. Daly | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 20,006 | 2,661,978 | - | - | Restricted Stock Units | |
| Merit Medical Systems Inc | Fred P. Lampropoulos | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 85.13 per share. | 20 Nov 2025 | 20,000 | 1,054,955 (1%) | 0% | 85.1 | 1,702,650 | Common Stock, No Par Value |
| Salarius Pharma Inc | Mark J. Rosenblum | Exec VP Finance, CFO | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 20 Nov 2025 | 20,000 | 20,177 (0%) | 0% | 0.8 | 16,000 | Common Stock |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 20,000 | 450,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 20 Nov 2025 | 20,000 | 18,000 | - | 7.0 | 140,074 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share. | 20 Nov 2025 | 20,000 | 38,000 | - | 1.9 | 37,400 | Class A Common Stock |
| Siebert Fin Corp | Andrew H. Reich | Director, EVP, COO CFO and Secretary | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 20,000 | 589,574 (1%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Arista Networks | Kenneth Duda | Director, President and CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 19,816 | 376,504 | - | - | Restricted Stock Unit-14 | |
| Arista Networks | Kenneth Duda | Director, President and CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 19,816 | 44,699 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Sean Mackay | SVP & Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.28 per share. | 20 Nov 2025 | 19,661 | 779,835 (1%) | 0% | 1.3 | 25,166 | Common Stock |
| Reddit Inc (Class A) | Andrew Vollero | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 187.78 per share. | 20 Nov 2025 | 19,637 | 264,531 | - | 187.8 | 3,687,436 | Class A Common Stock |
| Heritage Fin Corp | Bryan D. McDonald | President | Purchase of securities on an exchange or from another person at price $ 22.32 per share. | 20 Nov 2025 | 19,106 | 31,363 (0%) | 0% | 22.3 | 426,446 | Common Stock |
| Palantir | Stephen Cohen | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 155.31 per share. | 20 Nov 2025 | 19,068 | 290,159 | - | 155.3 | 2,961,430 | Class A Common Stock |
| Theravance Biopharma Inc | Brett A. Grimaud | SVP, GEN COUNSEL AND SECRETARY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.90 per share. | 20 Nov 2025 | 19,024 | 355,282 (0%) | 0% | 17.9 | 340,530 | Ordinary Shares |
| Palantir | Shyam Sankar | See Remarks | 20 Nov 2025 | 19,004 | 3,282,116 | - | - | Class B Common Stock | ||
| Palantir | Shyam Sankar | See Remarks | 20 Nov 2025 | 19,004 | 661,790 | - | - | Class A Common Stock | ||
| Lemonade Inc | John Peters | Chief Insurance Officer | Sale of securities on an exchange or to another person at price $ 72.77 per share. | 20 Nov 2025 | 18,930 | 83,467 | - | 72.8 | 1,377,536 | COMMON STOCK |
| Palantir | Shyam Sankar | See Remarks | Sale of securities on an exchange or to another person at price $ 172.77 per share. | 20 Nov 2025 | 18,720 | 644,515 | - | 172.8 | 3,234,286 | Class A Common Stock |
| Western Digital | Kris A. Sennesael | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 140.23 per share. | 20 Nov 2025 | 18,680 | 187,966 (0%) | 0% | 140.2 | 2,619,496 | Common Stock |
| Palantir | Shyam Sankar | See Remarks | Sale of securities on an exchange or to another person at price $ 157.25 per share. | 20 Nov 2025 | 18,631 | 755,868 | - | 157.3 | 2,929,743 | Class A Common Stock |
| Theravance Biopharma Inc | Aziz Sawaf | SVP & CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.90 per share. | 20 Nov 2025 | 18,627 | 336,795 (0%) | 0% | 17.9 | 333,423 | Ordinary Shares |
| Palantir | Shyam Sankar | See Remarks | Sale of securities on an exchange or to another person at price $ 156.26 per share. | 20 Nov 2025 | 18,600 | 643,013 | - | 156.3 | 2,906,438 | Class A Common Stock |
| Quad/Graphics Inc (Class A) | Joshua J. Golden | Chief Marketing Officer | Sale or transfer of securities back to the company at price $ 5.32 per share. | 20 Nov 2025 | 18,390 | 114,879 (0%) | 0% | 5.3 | 97,835 | Class A Common Stock |
| Palantir | Stephen Cohen | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 156.19 per share. | 20 Nov 2025 | 18,328 | 271,831 | - | 156.2 | 2,862,573 | Class A Common Stock |
| Pinterest Inc (Class A) | Matthew Madrigal | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.81 per share. | 20 Nov 2025 | 18,193 | 392,438 (0%) | 0% | 24.8 | 451,368 | Class A Common Stock |
| Palantir | Shyam Sankar | See Remarks | Sale of securities on an exchange or to another person at price $ 158.14 per share. | 20 Nov 2025 | 18,178 | 737,690 | - | 158.1 | 2,874,605 | Class A Common Stock |
| Catalyst Pharma Inc | David S. Tierney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 18,115 | 176,389 | - | - | Options to purchase common stock | |
| Catalyst Pharma Inc | Donald A. Denkhaus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 18,115 | 176,389 | - | - | Options to purchase common stock | |
| Catalyst Pharma Inc | Tamar Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 18,115 | 116,555 | - | - | Options to purchase common stock | |
| Catalyst Pharma Inc | Molly Harper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 18,115 | 145,389 | - | - | Options to purchase common stock | |
| Catalyst Pharma Inc | Daniel Curran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 18,115 | 58,115 | - | - | Options to purchase common stock | |
| Arista Networks | Kenneth Duda | Director, President and CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 124.81 per share. | 20 Nov 2025 | 17,764 | 26,935 (0%) | 0% | 124.8 | 2,217,125 | Common Stock |
| Chevron | John B. Hess | Director | Sale of securities on an exchange or to another person at price $ 150.85 per share. | 20 Nov 2025 | 17,557 | 853,045 (0%) | 0% | 150.8 | 2,648,463 | Common Stock |
| Palantir | Stephen Cohen | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 159.08 per share. | 20 Nov 2025 | 17,415 | 178,614 | - | 159.1 | 2,770,354 | Class A Common Stock |
| Palantir | Alexander C. Karp | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 160.16 per share. | 20 Nov 2025 | 17,365 | 6,622,154 | - | 160.2 | 2,781,204 | Class A Common Stock |
| Chevron | John B. Hess | Director | Sale of securities on an exchange or to another person at price $ 152.43 per share. | 20 Nov 2025 | 17,309 | 1,128,045 (0%) | 0% | 152.4 | 2,638,461 | Common Stock |
| Reddit Inc (Class A) | Jennifer L. Wong | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 192.31 per share. | 20 Nov 2025 | 16,962 | 1,213,706 | - | 192.3 | 3,261,962 | Class A Common Stock |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Sale of securities on an exchange or to another person at price $ 27.55 per share. | 20 Nov 2025 | 16,532 | 22,123 (0%) | 0% | 27.5 | 455,442 | Common Stock |
| Palantir | Shyam Sankar | See Remarks | Sale of securities on an exchange or to another person at price $ 172.00 per share. | 20 Nov 2025 | 16,512 | 663,235 | - | 172.0 | 2,840,011 | Class A Common Stock |
| Murphy USA Inc | R. Andrew Clyde | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 381.33 per share. | 20 Nov 2025 | 16,250 | 59,172 (0%) | 0% | 381.3 | 6,196,613 | Common Stock |
| Blend Labs Inc (Class A) | Winnie Ling | HEAD OF LEGAL AND PEOPLE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.04 per share. | 20 Nov 2025 | 15,954 | 395,927 | - | 3.0 | 48,500 | Class A Common Stock |
| DoorDash | Ravi Inukonda | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 196.16 per share. | 20 Nov 2025 | 15,945 | 197,897 | - | 196.2 | 3,127,771 | Class A Common Stock |
| DoorDash | Prabir Adarkar | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 196.16 per share. | 20 Nov 2025 | 15,660 | 888,619 | - | 196.2 | 3,071,866 | Class A Common Stock |
| RingCentral Inc (Class A) | Vaibhav Agarwal | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.12 per share. | 20 Nov 2025 | 15,456 | 180,564 (0%) | 0% | 26.1 | 403,711 | Class A Common Stock |
| Confluent Inc (Class A) | Ryan Norris Mac Ban | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 22.51 per share. | 20 Nov 2025 | 15,062 | 381,064 | - | 22.5 | 339,046 | Class A Common Stock |
| Futurefuel Corp | Roeland Polet | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.20 per share. | 20 Nov 2025 | 15,000 | 25,000 (0%) | 0% | 3.2 | 48,000 | Common Stock |
| DoorDash | Stanley Tang | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Nov 2025 | 15,000 | 0 | - | 0 | Class A Common Stock | |
| DoorDash | Stanley Tang | Director | Other type of transaction at price $ 0.00 per share. | 20 Nov 2025 | 15,000 | 3,748,401 | - | - | Class B Common Stock | |
| DoorDash | Stanley Tang | Director | Other type of transaction at price $ 0.00 per share. | 20 Nov 2025 | 15,000 | 15,000 | - | 0 | Class A Common Stock | |
| RingCentral Inc (Class A) | Vaibhav Agarwal | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.96 per share. | 20 Nov 2025 | 14,971 | 165,593 (0%) | 0% | 26.0 | 388,647 | Class A Common Stock |
| Palantir | Stephen Cohen | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 160.16 per share. | 20 Nov 2025 | 14,916 | 163,698 | - | 160.2 | 2,388,969 | Class A Common Stock |
| Reddit Inc (Class A) | Christopher Slowe | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 187.78 per share. | 20 Nov 2025 | 14,840 | 187,694 | - | 187.8 | 2,786,655 | Class A Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 555.67 per share. | 20 Nov 2025 | 14,450 | 35,525 (0%) | 0% | 555.7 | 8,029,432 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 14,450 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Coinbase Global Inc (Class A) | Emilie M. Choi | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 257.29 per share. | 20 Nov 2025 | 14,370 | 202,434 | - | 257.3 | 3,697,257 | Class A Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 65.90 per share. | 20 Nov 2025 | 14,299 | 234,232 (0%) | 0% | 65.9 | 942,361 | Common Stock |
| RingCentral Inc (Class A) | Vladimir Shmunis | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 26.13 per share. | 20 Nov 2025 | 14,221 | 349,762 (0%) | 0% | 26.1 | 371,538 | Class A Common Stock |
| CuriosityStream Inc - Ordinary Shares- Class A | Jonathan S. Huberman | Director | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 20 Nov 2025 | 14,116 | 1,210,169 | - | 5 | 70,580 | Common Stock |
| Palantir | Shyam Sankar | See Remarks | Sale of securities on an exchange or to another person at price $ 170.91 per share. | 20 Nov 2025 | 14,065 | 679,747 | - | 170.9 | 2,403,874 | Class A Common Stock |
| Match Group | Spencer M. Rascoff | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 31.84 per share. | 20 Nov 2025 | 14,000 | 165,128 (0%) | 0% | 31.8 | 445,691 | Common Stock, par value $0.001 |
| Confluent Inc (Class A) | Edward Jay Kreps | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 22.84 per share. | 20 Nov 2025 | 13,920 | 339,367 | - | 22.8 | 317,933 | Class A Common Stock |
| Chime Fin Inc (Class A) | Matthew Newcomb | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.43 per share. | 20 Nov 2025 | 13,888 | 523,039 | - | 18.4 | 255,956 | Class A Common Stock |
| Matthews Intl Corp (Class A) | Steven D. Gackenbach | EVP, Group Pres, Memorial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 13,800 | 117,944 (0%) | 0% | 0 | Class A Common Stock | |
| Astronics Corp | Peter J. Gundermann | Director, PRESIDENT/CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.72 per share. | 20 Nov 2025 | 13,700 | 95,613 (0%) | 0% | 27.7 | 379,764 | $.01 PV Com Stk |
| Astronics Corp | Peter J. Gundermann | Director, PRESIDENT/CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 13,700 | 0 | - | - | Option | |
| Astronics Corp | Peter J. Gundermann | Director, PRESIDENT/CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 13,700 | 0 | - | - | Option | |
| Astronics Corp | Peter J. Gundermann | Director, PRESIDENT/CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.72 per share. | 20 Nov 2025 | 13,700 | 95,613 (0%) | 0% | 27.7 | 379,764 | $.01 PV Com Stk |
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.35 per share. | 20 Nov 2025 | 13,664 | 216,126,448 (32%) | 0% | 1.3 | 18,446 | Common Stock |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 13,551 | 473,520 (0%) | 0% | 0 | ResMed Common Stock | |
| iBio Inc | William D. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 13,500 | 13,500 | - | - | Stock Option (right to buy) | |
| iBio Inc | David A. Arkowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 13,500 | 13,500 | - | - | Stock Option (right to buy) | |
| iBio Inc | Gary L. Sender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 13,500 | 13,500 | - | - | Stock Option (right to buy) | |
| iBio Inc | Evert B. Schimmelpennink | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 13,500 | 13,500 | - | - | Stock Option (right to buy) | |
| iBio Inc | Alexandra Kropotova | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 13,500 | 13,500 | - | - | Stock Option (right to buy) | |
| iBio Inc | Antonio Bernardino Guimaraes Parada | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 13,500 | 13,500 | - | - | Stock Option (right to buy) | |
| Cisco | Oliver Tuszik | EVP, Global Sales | Sale of securities on an exchange or to another person at price $ 79.21 per share. | 20 Nov 2025 | 13,353 | 197,039 (0%) | 0% | 79.2 | 1,057,691 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 192.53 per share. | 20 Nov 2025 | 13,339 | 30,908 | - | 192.5 | 2,568,198 | Common Stock |
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 191.45 per share. | 20 Nov 2025 | 13,331 | 163,438 (0%) | 0% | 191.4 | 2,552,180 | Class A Common Stock |
| CuriosityStream Inc - Ordinary Shares- Class A | Clinton Larry Stinchcomb | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.60 per share. | 20 Nov 2025 | 12,872 | 2,659,204 | - | 4.6 | 59,211 | Common Stock |
| Palantir | Alexander C. Karp | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 161.16 per share. | 20 Nov 2025 | 12,867 | 6,609,287 | - | 161.2 | 2,073,590 | Class A Common Stock |
| RingCentral Inc (Class A) | Kira Makagon | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.12 per share. | 20 Nov 2025 | 12,845 | 364,156 (0%) | 0% | 26.1 | 335,511 | Class A Common Stock |
| Standard BioTools Inc | Hanjoon Alex Kim | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.28 per share. | 20 Nov 2025 | 12,739 | 2,415,086 (3%) | 0% | 1.3 | 16,306 | Common Stock |
| Regeneron Pharma | Joseph J. Larosa | EVP General Counsel and Secret | Payment of exercise price or tax liability using portion of securities received from the company at price $ 736.77 per share. | 20 Nov 2025 | 12,686 | 22,839 (0%) | 0% | 736.8 | 9,346,664 | Common Stock |
| Chime Fin Inc (Class A) | Christopher Britt | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.43 per share. | 20 Nov 2025 | 12,678 | 344,780 | - | 18.4 | 233,656 | Class A Common Stock |
| Upstart Holdings Inc | Sanjay Datta | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 36.54 per share. | 20 Nov 2025 | 12,624 | 285,280 | - | 36.5 | 461,331 | Common Stock |
| Cloudflare Inc (Class A) | Michelle Zatlyn | Director, President and Board Co-Chair | Sale of securities on an exchange or to another person at price $ 188.46 per share. | 20 Nov 2025 | 12,598 | 37,598 (0%) | 0% | 188.5 | 2,374,176 | Class A Common Stock |
| Reddit Inc (Class A) | Jennifer L. Wong | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 191.21 per share. | 20 Nov 2025 | 12,585 | 1,230,668 | - | 191.2 | 2,406,378 | Class A Common Stock |
| Blue Owl Tech Finance Corp | Erik Bissonnette | President | Purchase of securities on an exchange or from another person at price $ 13.27 per share. | 20 Nov 2025 | 12,500 | 156,525 | - | 13.3 | 165,824 | Common Stock |
| Blend Labs Inc (Class A) | Oxana Tkach | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 12,500 | 90,280 | - | - | Class A Common Stock | |
| Blend Labs Inc (Class A) | Oxana Tkach | PRINCIPAL ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 12,500 | 62,500 | - | - | Restricted Stock Units | |
| EverQuote Inc (Class A) | Jayme Mendal | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 23.45 per share. | 20 Nov 2025 | 12,345 | 454,427 (3%) | 0% | 23.4 | 289,490 | Class A Common Stock |
| D.R. Horton | David V. Auld | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 12,261 | 23,151 | - | - | Restricted Stock Unit | |
| D.R. Horton | David V. Auld | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 12,261 | 950,383 (0%) | 0% | - | Common Stock | |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share. | 20 Nov 2025 | 12,220 | 38,655 (0%) | 0% | 7.5 | 91,772 | Common Stock |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 12,220 | 0 | - | - | Stock Option (right to buy) | |
| Figure Technology Solutions | Michael Scott Cagney | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 38.98 per share. | 20 Nov 2025 | 12,071 | 6,378,993 | - | 39.0 | 470,582 | Class A Common Stock |
| Figure Technology Solutions | June Ou | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 38.98 per share. | 20 Nov 2025 | 12,071 | 6,378,993 | - | 39.0 | 470,582 | Class A Common Stock |
| Matthews Intl Corp (Class A) | Brian D. Walters | EVP, Gen Counsel, and Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 12,000 | 91,763 (0%) | 0% | 0 | Class A Common Stock | |
| Reddit Inc (Class A) | Christopher Slowe | Chief Technology Officer | 20 Nov 2025 | 12,000 | 199,694 | - | 0 | Class A Common Stock | ||
| Reddit Inc (Class A) | Christopher Slowe | Chief Technology Officer | 20 Nov 2025 | 12,000 | 0 | - | - | Class B Common Stock | ||
| Reddit Inc (Class A) | Christopher Slowe | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 12,000 | 12,000 | - | - | Class B Common Stock | |
| Reddit Inc (Class A) | Christopher Slowe | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 12,000 | 57,464 | - | - | Stock Option (Right to Buy) | |
| MainStay MacKay DefinedTerm Municipal Opportunities Fund | Robert A. Dimella | Portfolio Manager | Sale of securities on an exchange or to another person at price $ 14.84 per share. | 20 Nov 2025 | 11,964 | 0 (0%) | 0% | 14.8 | 177,556 | Shares of beneficial interest |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 44.14 per share. | 20 Nov 2025 | 11,888 | 44,753 (0%) | 0% | 44.1 | 524,736 | Common Stock |
| Honest Co Inc (The ) | Brendan Sheehey | General Counsel | Sale of securities on an exchange or to another person at price $ 2.60 per share. | 20 Nov 2025 | 11,849 | 556,739 | - | 2.6 | 30,807 | Common Stock |
| Coinbase Global Inc (Class A) | Emilie M. Choi | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 11,738 | 210,728 | - | 0 | Class A Common Stock | |
| Coinbase Global Inc (Class A) | Emilie M. Choi | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 11,738 | 46,951 | - | - | Restricted Stock Units | |
| Astronics Corp | Peter J. Gundermann | Director, PRESIDENT/CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.35 per share. | 20 Nov 2025 | 11,707 | 83,906 (0%) | 0% | 49.3 | 577,740 | $.01 PV Com Stk |
| Astronics Corp | Peter J. Gundermann | Director, PRESIDENT/CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.35 per share. | 20 Nov 2025 | 11,707 | 83,906 (0%) | 0% | 49.3 | 577,740 | $.01 PV Com Stk |
| Harley-Davidson Inc | Luke Christopher Mansfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 23.21 per share. | 20 Nov 2025 | 11,500 | 12,055 (0%) | 0% | 23.2 | 266,954 | Common Stock |
| Praxis Precision Medicines Inc | Lauren Mastrocola | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 191.96 per share. | 20 Nov 2025 | 11,455 | 12,586 | - | 192.0 | 2,198,879 | Common Stock |
| CoreWeave Inc (Class A) | Nitin Agrawal | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 11,412 | 157,000 | - | - | Class A Common Stock | |
| CoreWeave Inc (Class A) | Nitin Agrawal | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 11,412 | 148,363 | - | - | Restricted Stock Units | |
| Matthews Intl Corp (Class A) | Steven F. Nicola | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 11,400 | 0 | - | - | Restricted Share Units | |
| Reddit Inc (Class A) | Jennifer L. Wong | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 195.16 per share. | 20 Nov 2025 | 11,393 | 1,184,528 | - | 195.2 | 2,223,458 | Class A Common Stock |
| Coinbase Global Inc (Class A) | Emilie M. Choi | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 11,166 | 0 | - | - | Restricted Stock Units | |
| Coinbase Global Inc (Class A) | Emilie M. Choi | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 11,166 | 198,990 | - | 0 | Class A Common Stock | |
| Yelp Inc | Sam Eaton | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.85 per share. | 20 Nov 2025 | 11,093 | 122,880 (0%) | 0% | 28.8 | 320,033 | Common Stock |
| Palantir | Stephen Cohen | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 161.16 per share. | 20 Nov 2025 | 11,052 | 152,646 | - | 161.2 | 1,781,093 | Class A Common Stock |
| Strata Critical Medical Inc (Class A) | Reginald L. Love | Director | Sale of securities on an exchange or to another person at price $ 4.37 per share. | 20 Nov 2025 | 11,000 | 113,897 | - | 4.4 | 48,070 | Class A common stock, $0.0001 par value per share |
| Arista Networks | Chantelle Yvette Breithaupt | Senior Vice President, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 10,916 | 52,852 (0%) | 0% | 0 | Common Stock | |
| Arista Networks | Chantelle Yvette Breithaupt | Senior Vice President, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 10,916 | 98,260 | - | - | Restricted Stock Unit-1 | |
| RingCentral Inc (Class A) | John Marlow | SVP, CAdO & GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.12 per share. | 20 Nov 2025 | 10,897 | 303,410 (0%) | 0% | 26.1 | 284,630 | Class A Common Stock |
| Reddit Inc (Class A) | Jennifer L. Wong | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 193.28 per share. | 20 Nov 2025 | 10,884 | 1,202,822 | - | 193.3 | 2,103,660 | Class A Common Stock |
| Lightbridge Corp | Seth Grae | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.53 per share. | 20 Nov 2025 | 10,791 | 742,525 (22%) | 0% | 14.5 | 156,793 | Common Stock |
| Clearfield Inc | John P. Hill | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 10,788 | 177,616 | - | 0 | Restricted Stock | |
| Clearfield Inc | Cheryl Podzimek Beranek | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 10,788 | 490,899 | - | 0 | Restricted Stock | |
| Blend Labs Inc (Class A) | Oxana Tkach | PRINCIPAL ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.04 per share. | 20 Nov 2025 | 10,763 | 79,517 | - | 3.0 | 32,720 | Class A Common Stock |
| Exelixis Inc | Patrick J. Haley | EVP, Commercial | Sale of securities on an exchange or to another person at price $ 41.77 per share. | 20 Nov 2025 | 10,648 | 0 (0%) | 0% | 41.8 | 444,767 | Common Stock |
| Honest Co Inc (The ) | Stephen Winchell | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 2.60 per share. | 20 Nov 2025 | 10,595 | 399,662 | - | 2.6 | 27,547 | Common Stock |
| Chime Fin Inc (Class A) | Amine Asmerom | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.43 per share. | 20 Nov 2025 | 10,577 | 306,759 | - | 18.4 | 194,934 | Class A Common Stock |
| Catalyst Pharma Inc | Patrick J. McEnany | Director, Chairman of Board of Directors | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 10,540 | 1,883,591 | - | - | Restricted Stock Units | |
| My Size Inc | Ronen Luzon | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.76 per share. | 20 Nov 2025 | 10,500 | 54,500 (2%) | 0% | 0.8 | 7,980 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.